VAR,Variable,UNIT,Measure,COU,Country,YEA,Year,Value,Flag Codes,Flags
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,AUS,Australia,2000,2000,74,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,AUS,Australia,2001,2001,78,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,AUS,Australia,2002,2002,76.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,AUS,Australia,2003,2003,76.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,AUS,Australia,2004,2004,79.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,AUS,Australia,2006,2006,77.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,AUS,Australia,2009,2009,74.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,AUT,Austria,2006,2006,36.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,AUT,Austria,2014,2014,20.3,B,Break
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,BEL,Belgium,2001,2001,58,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,BEL,Belgium,2004,2004,64,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,BEL,Belgium,2008,2008,65,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,BEL,Belgium,2013,2013,58,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,BEL,Belgium,2018,2018,59.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CAN,Canada,2000,2000,63,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CAN,Canada,2003,2003,67.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CAN,Canada,2005,2005,70.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CAN,Canada,2007,2007,69,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CAN,Canada,2008,2008,66.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CAN,Canada,2009,2009,66.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CAN,Canada,2010,2010,59.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CAN,Canada,2011,2011,64.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CAN,Canada,2012,2012,64.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CAN,Canada,2013,2013,64.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CAN,Canada,2014,2014,63.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CAN,Canada,2015,2015,60.8,B,Break
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CAN,Canada,2016,2016,59.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CAN,Canada,2017,2017,61.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CAN,Canada,2018,2018,59,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CZE,Czech Republic,2002,2002,16.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CZE,Czech Republic,2008,2008,19.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CZE,Czech Republic,2010,2010,17.4,B,Break
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CZE,Czech Republic,2011,2011,17.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CZE,Czech Republic,2012,2012,18,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CZE,Czech Republic,2013,2013,19.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CZE,Czech Republic,2014,2014,18.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CZE,Czech Republic,2015,2015,19.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CZE,Czech Republic,2016,2016,20.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CZE,Czech Republic,2017,2017,20.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CZE,Czech Republic,2018,2018,21.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DNK,Denmark,2002,2002,6.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DNK,Denmark,2003,2003,19.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DNK,Denmark,2004,2004,30.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DNK,Denmark,2005,2005,34,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DNK,Denmark,2006,2006,33.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DNK,Denmark,2007,2007,39.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DNK,Denmark,2008,2008,51,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DNK,Denmark,2009,2009,50,B,Break
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DNK,Denmark,2010,2010,47,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DNK,Denmark,2011,2011,48,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DNK,Denmark,2012,2012,45,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DNK,Denmark,2013,2013,47,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DNK,Denmark,2014,2014,45,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DNK,Denmark,2015,2015,44,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DNK,Denmark,2016,2016,47,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DNK,Denmark,2017,2017,50,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DNK,Denmark,2018,2018,52,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FIN,Finland,2001,2001,25,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FIN,Finland,2002,2002,43,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FIN,Finland,2003,2003,45,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FIN,Finland,2004,2004,46,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FIN,Finland,2005,2005,52,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FIN,Finland,2006,2006,46,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FIN,Finland,2007,2007,48.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FIN,Finland,2008,2008,51,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FIN,Finland,2009,2009,46,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FIN,Finland,2010,2010,40.3,B,Break
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FIN,Finland,2011,2011,38.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FIN,Finland,2012,2012,36.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FIN,Finland,2013,2013,41,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FIN,Finland,2014,2014,40,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FIN,Finland,2015,2015,43.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FIN,Finland,2016,2016,47.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FIN,Finland,2017,2017,47.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FIN,Finland,2018,2018,49.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FRA,France,2000,2000,65,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FRA,France,2001,2001,65,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FRA,France,2002,2002,67,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FRA,France,2003,2003,65,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FRA,France,2004,2004,63.9,B,Break
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FRA,France,2005,2005,63.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FRA,France,2006,2006,63.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FRA,France,2007,2007,63.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FRA,France,2008,2008,64.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FRA,France,2009,2009,63.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FRA,France,2010,2010,56.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FRA,France,2011,2011,55.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FRA,France,2012,2012,53.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FRA,France,2013,2013,51.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FRA,France,2014,2014,48.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FRA,France,2015,2015,50.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FRA,France,2016,2016,50,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FRA,France,2017,2017,49.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,FRA,France,2018,2018,51,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DEU,Germany,2001,2001,55.8,D,Difference in methodology
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DEU,Germany,2003,2003,48,D,Difference in methodology
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DEU,Germany,2005,2005,63,D,Difference in methodology
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DEU,Germany,2006,2006,60,D,Difference in methodology
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DEU,Germany,2007,2007,56,D,Difference in methodology
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DEU,Germany,2009,2009,61.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DEU,Germany,2010,2010,56.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DEU,Germany,2012,2012,58.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DEU,Germany,2013,2013,37.2,B; D,Break; Difference in methodology
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DEU,Germany,2014,2014,38.1,D,Difference in methodology
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DEU,Germany,2015,2015,36.5,D,Difference in methodology
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DEU,Germany,2016,2016,35.3,D,Difference in methodology
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,DEU,Germany,2017,2017,34.8,D,Difference in methodology
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,GRC,Greece,2009,2009,41.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,GRC,Greece,2014,2014,48.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,GRC,Greece,2018,2018,56.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,HUN,Hungary,2002,2002,36.8,D,Difference in methodology
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,HUN,Hungary,2003,2003,38.9,D,Difference in methodology
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,HUN,Hungary,2004,2004,37.9,D,Difference in methodology
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,HUN,Hungary,2005,2005,37.1,D,Difference in methodology
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,HUN,Hungary,2006,2006,34,D,Difference in methodology
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,HUN,Hungary,2007,2007,34.2,D,Difference in methodology
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,HUN,Hungary,2008,2008,37.8,D,Difference in methodology
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,HUN,Hungary,2009,2009,31.6,D,Difference in methodology
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,HUN,Hungary,2010,2010,29.7,B,Break
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,HUN,Hungary,2011,2011,31.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,HUN,Hungary,2012,2012,30.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,HUN,Hungary,2013,2013,29,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,HUN,Hungary,2014,2014,27.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,HUN,Hungary,2015,2015,26,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,HUN,Hungary,2016,2016,24,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,HUN,Hungary,2017,2017,26.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,HUN,Hungary,2018,2018,24.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ISL,Iceland,2015,2015,43,D,Difference in methodology
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ISL,Iceland,2016,2016,47,D,Difference in methodology
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ISL,Iceland,2017,2017,45,D,Difference in methodology
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ISL,Iceland,2018,2018,49.4,B,Break
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ISL,Iceland,2019,2019,47.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,IRL,Ireland,2003,2003,62.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,IRL,Ireland,2004,2004,61.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,IRL,Ireland,2005,2005,63,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,IRL,Ireland,2006,2006,60.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,IRL,Ireland,2007,2007,61.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,IRL,Ireland,2008,2008,70.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,IRL,Ireland,2009,2009,53.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,IRL,Ireland,2010,2010,63.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,IRL,Ireland,2011,2011,56.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,IRL,Ireland,2012,2012,56.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,IRL,Ireland,2013,2013,59.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,IRL,Ireland,2014,2014,60.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,IRL,Ireland,2015,2015,55.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,IRL,Ireland,2016,2016,54.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,IRL,Ireland,2017,2017,57.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,IRL,Ireland,2018,2018,68.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ITA,Italy,2000,2000,40.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ITA,Italy,2001,2001,50.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ITA,Italy,2002,2002,55.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ITA,Italy,2003,2003,60.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ITA,Italy,2004,2004,63.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ITA,Italy,2005,2005,66.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ITA,Italy,2006,2006,68.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ITA,Italy,2007,2007,66.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ITA,Italy,2008,2008,64.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ITA,Italy,2009,2009,66.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ITA,Italy,2010,2010,65.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ITA,Italy,2011,2011,62.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ITA,Italy,2012,2012,62.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ITA,Italy,2013,2013,54.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ITA,Italy,2014,2014,55.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ITA,Italy,2015,2015,48.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ITA,Italy,2016,2016,49.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ITA,Italy,2017,2017,52,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ITA,Italy,2018,2018,52.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ITA,Italy,2019,2019,53.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,JPN,Japan,2001,2001,28,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,JPN,Japan,2002,2002,35,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,JPN,Japan,2003,2003,43,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,JPN,Japan,2004,2004,48,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,JPN,Japan,2005,2005,49,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,JPN,Japan,2006,2006,48,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,JPN,Japan,2007,2007,53,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,JPN,Japan,2008,2008,56,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,JPN,Japan,2009,2009,50,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,JPN,Japan,2010,2010,53,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,JPN,Japan,2011,2011,52,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,JPN,Japan,2012,2012,50,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,JPN,Japan,2013,2013,50,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,JPN,Japan,2014,2014,50,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,JPN,Japan,2015,2015,51,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,JPN,Japan,2016,2016,50,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,JPN,Japan,2017,2017,48,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,KOR,Korea,2004,2004,75.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,KOR,Korea,2005,2005,77.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,KOR,Korea,2007,2007,70.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,KOR,Korea,2008,2008,73.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,KOR,Korea,2009,2009,74.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,KOR,Korea,2010,2010,77.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,KOR,Korea,2011,2011,79.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,KOR,Korea,2012,2012,77.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,KOR,Korea,2014,2014,79.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,KOR,Korea,2015,2015,81.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,KOR,Korea,2016,2016,84.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,KOR,Korea,2017,2017,82.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,KOR,Korea,2018,2018,85.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LUX,Luxembourg,2001,2001,42.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LUX,Luxembourg,2002,2002,46,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LUX,Luxembourg,2003,2003,49.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LUX,Luxembourg,2004,2004,51,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LUX,Luxembourg,2005,2005,54.3,B,Break
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LUX,Luxembourg,2006,2006,51.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LUX,Luxembourg,2007,2007,53,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LUX,Luxembourg,2008,2008,53.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LUX,Luxembourg,2009,2009,52.3,B,Break
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LUX,Luxembourg,2010,2010,45.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LUX,Luxembourg,2011,2011,45.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LUX,Luxembourg,2012,2012,43.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LUX,Luxembourg,2013,2013,42.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LUX,Luxembourg,2014,2014,40.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LUX,Luxembourg,2015,2015,39.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LUX,Luxembourg,2016,2016,38,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LUX,Luxembourg,2017,2017,37.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LUX,Luxembourg,2018,2018,39.8,P,Provisional value
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,MEX,Mexico,2006,2006,51.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,MEX,Mexico,2007,2007,34.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,MEX,Mexico,2008,2008,76.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,MEX,Mexico,2009,2009,88.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,MEX,Mexico,2010,2010,70.3,B,Break
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,MEX,Mexico,2011,2011,72.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,MEX,Mexico,2012,2012,67.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,MEX,Mexico,2013,2013,78.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,MEX,Mexico,2014,2014,82.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NLD,Netherlands,2000,2000,76,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NLD,Netherlands,2001,2001,76,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NLD,Netherlands,2002,2002,78,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NLD,Netherlands,2003,2003,77,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NLD,Netherlands,2004,2004,73,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NLD,Netherlands,2005,2005,77,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NLD,Netherlands,2006,2006,75,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NLD,Netherlands,2007,2007,78,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NLD,Netherlands,2008,2008,77,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NLD,Netherlands,2009,2009,74,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NLD,Netherlands,2012,2012,73.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NLD,Netherlands,2013,2013,68.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NLD,Netherlands,2014,2014,72,B,Break
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NLD,Netherlands,2015,2015,66.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NLD,Netherlands,2016,2016,64.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NLD,Netherlands,2017,2017,64,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NLD,Netherlands,2018,2018,62.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NZL,New Zealand,2002,2002,51,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NZL,New Zealand,2003,2003,63.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NZL,New Zealand,2004,2004,58,B,Break
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NZL,New Zealand,2005,2005,60.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NZL,New Zealand,2006,2006,63.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NZL,New Zealand,2007,2007,63.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NZL,New Zealand,2008,2008,63.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NZL,New Zealand,2009,2009,66.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NZL,New Zealand,2010,2010,66.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NZL,New Zealand,2011,2011,65.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NZL,New Zealand,2012,2012,64.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NZL,New Zealand,2013,2013,69,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NZL,New Zealand,2014,2014,69,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NZL,New Zealand,2015,2015,67.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NZL,New Zealand,2016,2016,67,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NZL,New Zealand,2017,2017,65,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NZL,New Zealand,2018,2018,65,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NZL,New Zealand,2019,2019,62,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NOR,Norway,2009,2009,43.9,E,Estimated value
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NOR,Norway,2010,2010,7.7,E,Estimated value
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NOR,Norway,2011,2011,14.1,E,Estimated value
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NOR,Norway,2012,2012,11.4,E,Estimated value
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NOR,Norway,2013,2013,30.9,E; B,Estimated value; Break
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NOR,Norway,2014,2014,26.9,E,Estimated value
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NOR,Norway,2015,2015,27,E,Estimated value
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NOR,Norway,2016,2016,38,E,Estimated value
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NOR,Norway,2017,2017,34.4,E,Estimated value
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,NOR,Norway,2018,2018,38.2,E,Estimated value
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,POL,Poland,2009,2009,12.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,POL,Poland,2014,2014,9.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,PRT,Portugal,2001,2001,41.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,PRT,Portugal,2002,2002,36.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,PRT,Portugal,2003,2003,46.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,PRT,Portugal,2004,2004,39,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,PRT,Portugal,2005,2005,41.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,PRT,Portugal,2006,2006,50.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,PRT,Portugal,2007,2007,51,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,PRT,Portugal,2008,2008,53.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,PRT,Portugal,2009,2009,52.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,PRT,Portugal,2010,2010,48.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,PRT,Portugal,2011,2011,43.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,PRT,Portugal,2012,2012,44.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,PRT,Portugal,2013,2013,49.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,PRT,Portugal,2014,2014,50.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,PRT,Portugal,2015,2015,50.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,PRT,Portugal,2016,2016,57.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,PRT,Portugal,2017,2017,60.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVK,Slovak Republic,2000,2000,20.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVK,Slovak Republic,2001,2001,31.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVK,Slovak Republic,2003,2003,37.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVK,Slovak Republic,2004,2004,22.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVK,Slovak Republic,2005,2005,29.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVK,Slovak Republic,2006,2006,25.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVK,Slovak Republic,2007,2007,33.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVK,Slovak Republic,2008,2008,35.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVK,Slovak Republic,2009,2009,30.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVK,Slovak Republic,2010,2010,23.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVK,Slovak Republic,2011,2011,21.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVK,Slovak Republic,2012,2012,15.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVK,Slovak Republic,2013,2013,15.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVK,Slovak Republic,2014,2014,14.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVK,Slovak Republic,2015,2015,13.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVK,Slovak Republic,2016,2016,13.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVK,Slovak Republic,2017,2017,13,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVK,Slovak Republic,2018,2018,12.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ESP,Spain,2000,2000,61.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ESP,Spain,2001,2001,61.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ESP,Spain,2002,2002,67.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ESP,Spain,2003,2003,68,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ESP,Spain,2004,2004,68.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ESP,Spain,2005,2005,70.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ESP,Spain,2006,2006,67.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ESP,Spain,2007,2007,62.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ESP,Spain,2008,2008,65.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ESP,Spain,2009,2009,65.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ESP,Spain,2010,2010,56.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ESP,Spain,2011,2011,57.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ESP,Spain,2012,2012,57,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ESP,Spain,2013,2013,56.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ESP,Spain,2014,2014,56.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ESP,Spain,2015,2015,56.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ESP,Spain,2016,2016,55.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ESP,Spain,2017,2017,55.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ESP,Spain,2018,2018,54.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ESP,Spain,2019,2019,54.9,P,Provisional value
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SWE,Sweden,2003,2003,51,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SWE,Sweden,2004,2004,55,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SWE,Sweden,2005,2005,61,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SWE,Sweden,2006,2006,57,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SWE,Sweden,2007,2007,58,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SWE,Sweden,2008,2008,65.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SWE,Sweden,2009,2009,44,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SWE,Sweden,2010,2010,55.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SWE,Sweden,2011,2011,46.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SWE,Sweden,2012,2012,44.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SWE,Sweden,2013,2013,45.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SWE,Sweden,2014,2014,49.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SWE,Sweden,2015,2015,49.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SWE,Sweden,2016,2016,49.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SWE,Sweden,2017,2017,49.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SWE,Sweden,2018,2018,52.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHE,Switzerland,2000,2000,51,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHE,Switzerland,2001,2001,54,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHE,Switzerland,2002,2002,55,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHE,Switzerland,2003,2003,58,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHE,Switzerland,2004,2004,57,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHE,Switzerland,2005,2005,59,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHE,Switzerland,2006,2006,61,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHE,Switzerland,2007,2007,56,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHE,Switzerland,2010,2010,46,B,Break
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,TUR,Turkey,2008,2008,9.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,TUR,Turkey,2010,2010,12.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,TUR,Turkey,2012,2012,13.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,TUR,Turkey,2014,2014,9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,TUR,Turkey,2016,2016,7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,GBR,United Kingdom,2000,2000,65,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,GBR,United Kingdom,2001,2001,68,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,GBR,United Kingdom,2002,2002,69,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,GBR,United Kingdom,2003,2003,71,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,GBR,United Kingdom,2004,2004,71,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,GBR,United Kingdom,2005,2005,75,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,GBR,United Kingdom,2006,2006,75.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,GBR,United Kingdom,2007,2007,73.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,GBR,United Kingdom,2008,2008,73.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,GBR,United Kingdom,2009,2009,72.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,GBR,United Kingdom,2010,2010,72.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,GBR,United Kingdom,2011,2011,74,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,GBR,United Kingdom,2012,2012,73.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,GBR,United Kingdom,2013,2013,73.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,GBR,United Kingdom,2014,2014,72.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,GBR,United Kingdom,2015,2015,71.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,GBR,United Kingdom,2016,2016,70.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,GBR,United Kingdom,2017,2017,72.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,GBR,United Kingdom,2018,2018,72,P,Provisional value
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,USA,United States,2000,2000,64.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,USA,United States,2001,2001,63,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,USA,United States,2002,2002,65.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,USA,United States,2003,2003,65.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,USA,United States,2004,2004,64.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,USA,United States,2005,2005,59.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,USA,United States,2006,2006,64.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,USA,United States,2007,2007,66.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,USA,United States,2008,2008,66.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,USA,United States,2009,2009,66.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,USA,United States,2010,2010,63.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,USA,United States,2011,2011,67,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,USA,United States,2012,2012,66.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,USA,United States,2013,2013,67.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,USA,United States,2014,2014,70,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,USA,United States,2015,2015,69.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,USA,United States,2016,2016,67.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,USA,United States,2017,2017,67.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,USA,United States,2018,2018,68.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHL,Chile,2001,2001,94.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHL,Chile,2002,2002,76.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHL,Chile,2003,2003,80.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHL,Chile,2004,2004,79.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHL,Chile,2005,2005,73.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHL,Chile,2006,2006,82,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHL,Chile,2007,2007,84.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHL,Chile,2008,2008,78.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHL,Chile,2009,2009,87.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHL,Chile,2010,2010,57.7,B,Break
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHL,Chile,2011,2011,62.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHL,Chile,2012,2012,73.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHL,Chile,2013,2013,76.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHL,Chile,2014,2014,74.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHL,Chile,2015,2015,55,B,Break
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHL,Chile,2016,2016,54,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHL,Chile,2017,2017,59,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHL,Chile,2018,2018,64.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,CHL,Chile,2019,2019,68.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,EST,Estonia,2008,2008,1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,EST,Estonia,2009,2009,1.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,EST,Estonia,2010,2010,1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,EST,Estonia,2011,2011,0.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,EST,Estonia,2012,2012,0.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,EST,Estonia,2013,2013,1.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,EST,Estonia,2014,2014,1.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,EST,Estonia,2015,2015,1.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,EST,Estonia,2016,2016,2.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,EST,Estonia,2017,2017,4.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,EST,Estonia,2018,2018,10.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ISR,Israel,2000,2000,44.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ISR,Israel,2002,2002,45.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ISR,Israel,2003,2003,43.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ISR,Israel,2004,2004,48.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ISR,Israel,2005,2005,50.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ISR,Israel,2006,2006,44.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ISR,Israel,2007,2007,51.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ISR,Israel,2008,2008,56.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ISR,Israel,2009,2009,56.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ISR,Israel,2010,2010,57.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ISR,Israel,2011,2011,61,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ISR,Israel,2012,2012,57.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ISR,Israel,2013,2013,61.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ISR,Israel,2014,2014,63.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ISR,Israel,2015,2015,65.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ISR,Israel,2016,2016,62.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ISR,Israel,2017,2017,59.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ISR,Israel,2018,2018,58.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,ISR,Israel,2019,2019,59.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVN,Slovenia,2000,2000,35,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVN,Slovenia,2001,2001,29,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVN,Slovenia,2002,2002,26,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVN,Slovenia,2003,2003,33,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVN,Slovenia,2004,2004,30,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVN,Slovenia,2005,2005,33.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVN,Slovenia,2006,2006,27.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVN,Slovenia,2007,2007,25.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVN,Slovenia,2008,2008,25.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVN,Slovenia,2009,2009,21.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVN,Slovenia,2010,2010,17.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVN,Slovenia,2011,2011,15.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVN,Slovenia,2012,2012,14.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVN,Slovenia,2013,2013,12.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVN,Slovenia,2014,2014,10.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVN,Slovenia,2015,2015,10.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVN,Slovenia,2016,2016,9.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVN,Slovenia,2017,2017,11.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,SVN,Slovenia,2018,2018,12.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LVA,Latvia,2007,2007,3.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LVA,Latvia,2008,2008,2.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LVA,Latvia,2009,2009,2.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LVA,Latvia,2010,2010,1.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LVA,Latvia,2011,2011,2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LVA,Latvia,2012,2012,1.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LVA,Latvia,2013,2013,3.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LVA,Latvia,2014,2014,2.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LVA,Latvia,2015,2015,2.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LVA,Latvia,2016,2016,4.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LVA,Latvia,2017,2017,6.9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LVA,Latvia,2018,2018,7.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LVA,Latvia,2019,2019,11.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LTU,Lithuania,2005,2005,1.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LTU,Lithuania,2006,2006,1.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LTU,Lithuania,2007,2007,12.5,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LTU,Lithuania,2008,2008,11.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LTU,Lithuania,2009,2009,11.2,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LTU,Lithuania,2010,2010,9.1,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LTU,Lithuania,2011,2011,9,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LTU,Lithuania,2012,2012,9.7,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LTU,Lithuania,2013,2013,9.8,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LTU,Lithuania,2014,2014,10.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LTU,Lithuania,2015,2015,9.6,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LTU,Lithuania,2016,2016,11.3,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LTU,Lithuania,2017,2017,13.4,,
ACATIFLU,Immunisation: Influenza,FLUAGETX,% of population aged 65 years and over,LTU,Lithuania,2018,2018,14.8,,